HOUT-17. A PRELIMINARY DATA REPORT ON A PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA

door Bota, Daniela, Chung, Jinah, Carrillo, Jose, Kong, Xiao-Tang, Fu, Beverly, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil, Stathopoulos, Apostolos
Gepubliceerd in Neuro Oncol (2017)

ATIM-42. DOUBLE-BLINDED, PLACEBO CONTROLLED PHASE 2 STUDY OF ERC1671 IN RECURRENT GLIOBLASTOMA: OS CORRELATIONS WITH INITIAL AND MAXIMUM CD4+T LYMPHOCYTE COUNT IN THE PERIPHERAL BL...

door Bota, Daniela, Taylor, Thomas, Xiao-Tang, Kong, Fu, Beverly, Alsharif, Mohamad, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil, Stathopoulos, Apostolos
Gepubliceerd in Neuro Oncol (2019)

ET-54 IMMUNOTHERAPY BASED ON TUMOR TRANSPLANT ANTIGEN RECOGNITION EMERGES AS A PROMISING STRATEGY FOR RECURRENT GLIOBLASTOMA MULTIFORME (GBM) PATIENTS

door Schijns, Virgil, Pretto, Chrystel, Devillers, Laurent, Pierre, Denis, Hofman, Florence, Kruse, Carol, Chen, Thomas, Oertel, Joachim, Hantos, Peter, Bota, Daniela, Stathopoulos, Apostolos
Gepubliceerd in 2014

Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation

door Stathopoulos, Apostolis, Pretto, Chrystel, Devillers, Laurent, Pierre, Denis, Hofman, Florence M., Kruse, Carol, Jadus, Martin, Chen, Thomas C., Schijns, Virgil E.J.C.
Gepubliceerd in 2012

Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report

door Bota, Daniela A, Alexandru-Abrams, Daniela, Pretto, Chrystel, Hofman, Florence M, Chen, Thomas C, Fu, Beverly, Carrillo, Jose A, Schijns, Virgil EJC, Stathopoulos, Apostolos
Gepubliceerd in Perm J (2015)

Exploring the Therapeutic Efficacy of Glioma Vaccines Based on Allo- and Syngeneic Antigens and Distinct Immunological Costimulation Activators

door Stathopoulos, Apostolos, Pretto, Chrystel, Devillers, Laurent, Pierre, Denis, Hofman, Florence M., Epstein, Alan L., Farghadani, Hooman, Kruse, Carol A., Jadus, Martin R., Chen, Thomas C., Schijns, Virgil E.J.C.
Gepubliceerd in 2012

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4(+) T-lymphocyte counts

door Bota, Daniela A, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-Tang, Fu, Beverly D, Hsu, Frank PK, Schönthal, Axel H, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil EJC, Stathopoulos, Apostolos
Gepubliceerd in CNS Oncol (2018)

ATIM-28. PHASE 2 STUDY OF ERC1671 PLUS BEVACIZUMAB VS BEVACIZUMAB PLUS PLACEBO IN RECURRENT GBM INTERIM RESULTS AND CORRELATIONS WITH CD4+ T LYMPHOCYTE COUNTS

door Bota, Daniela A, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A, Kong, Xiao-tang, Beverly Fu, Dan, Hsu, Frank P K, Schönthal, Alex H, Hofman, Florence M, Chen, Thomas C, Zidovetzki, Raphael, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil E J C, Stathopoulos, Apostolos
Gepubliceerd in Neuro Oncol (2018)

Therapeutic Immunization against Glioblastoma

door Schijns, Virgil E. J. C., Pretto, Chrystel, Strik, Anna M., Gloudemans-Rijkers, Rianne, Devillers, Laurent, Pierre, Denis, Chung, Jinah, Dandekar, Manisha, Carrillo, Jose A., Kong, Xiao-Tang, Fu, Beverly D., Hsu, Frank P. K., Hofman, Florence M., Chen, Thomas C., Zidovetzki, Raphael, Bota, Daniela A., Stathopoulos, Apostolos
Gepubliceerd in Int J Mol Sci (2018)